Diagnosis of Prostate Cancer in Primary Care: Navigating Updated Clinical Guidance

Overview

Journal Br J Gen Pract

Specialty Public Health

Date 2023 Jan 26

PMID 36702599

Authors

Samuel Wd Merriel

Andrew Seggie

Hashim Ahmed

Affiliations

Soon will be listed here.

Citing Articles

Efficiency of evidence-based collaborative nursing on complications, negative emotions and quality of live in radical prostatectomy.

Wu X, Zang X Am J Transl Res. 2025; 17(1):349-357.

PMID: 39959190 PMC: 11826179. DOI: 10.62347/DZDL1914.

Factors affecting prostate cancer detection through asymptomatic prostate-specific antigen testing in primary care in England: evidence from the 2018 National Cancer Diagnosis Audit.

Merriel S, Merriel S, Akter N, Zakkak N, Swann R, McPhail S Br J Gen Pract. 2024; .

PMID: 39401928 PMC: 11881005. DOI: 10.3399/BJGP.2024.0376.

Androgen receptor modulatory miR-1271-5p can promote hormone sensitive prostate cancer cell growth.

Kalofonou F, Leach D, Powell S, Waxman J, Fletcher C, Bevan C Front Oncol. 2024; 14:1440612.

PMID: 39267821 PMC: 11390458. DOI: 10.3389/fonc.2024.1440612.

Examining the trend of mortality of genitourinary system cancers in Babol, North Iran (2013-2021).

Ebrahimi P, Karami M, Hosseini-Berneti S, Lashkarbolouki A, Keshtegar S, Ghezel M BMC Urol. 2024; 24(1):161.

PMID: 39080636 PMC: 11289959. DOI: 10.1186/s12894-024-01523-7.

Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review.

Aveta A, Cilio S, Contieri R, Spena G, Napolitano L, Manfredi C Int J Mol Sci. 2023; 24(13).

PMID: 37446024 PMC: 10341705. DOI: 10.3390/ijms241310846.

References

Pickles K, Carter S, Rychetnik L, Entwistle V . Doctors' perspectives on PSA testing illuminate established differences in prostate cancer screening rates between Australia and the UK: a qualitative study. BMJ Open. 2016; 6(12):e011932. PMC: 5168698. DOI: 10.1136/bmjopen-2016-011932. View

Ahmed H, El-Shater Bosaily A, Brown L, Gabe R, Kaplan R, Parmar M . Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017; 389(10071):815-822. DOI: 10.1016/S0140-6736(16)32401-1. View

Light A, Burns-Cox N, Maccormick A, John J, McGrath J, Gnanapragasam V . The diagnostic impact of UK regional variations in age-specific prostate-specific antigen guidelines. BJU Int. 2021; 128(3):298-300. DOI: 10.1111/bju.15484. View

Bass E, Ahmed H . Age-related PSA testing for prostate cancer: NICE recommendation 1.6.3. BJU Int. 2022; 131(1):130-131. DOI: 10.1111/bju.15859. View